Jaguar Health (JAGX) Revenue (QoQ) (2015 - 2026)
Jaguar Health (JAGX) Revenue (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 526.65% |
| Dec 31, 2025 | 4.93% |
| Sep 30, 2025 | 3.49% |
| Jun 30, 2025 | 34.55% |
| Mar 31, 2025 | -36.91% |
| Dec 31, 2024 | 12.90% |
| Sep 30, 2024 | 14.22% |
| Jun 30, 2024 | 15.74% |
| Mar 31, 2024 | 2.22% |
| Dec 31, 2023 | -18.24% |
| Sep 30, 2023 | 7.08% |
| Jun 30, 2023 | 5,737.78% |
| Mar 31, 2023 | 40.63% |
| Dec 31, 2022 | -98.98% |
| Sep 30, 2022 | 7.26% |
| Jun 30, 2022 | 14,505.00% |
| Mar 31, 2022 | -99.04% |
| Dec 31, 2021 | 238.21% |
| Sep 30, 2021 | 62.27% |
| Jun 30, 2021 | -68.63% |